GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (LTS:0RPD) » Definitions » Price-to-Operating-Cash-Flow

Vifor Pharma AG (LTS:0RPD) Price-to-Operating-Cash-Flow : 20.40 (As of Apr. 27, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Vifor Pharma AG Price-to-Operating-Cash-Flow?

As of today (2024-04-27), Vifor Pharma AG's share price is CHF165.55. Vifor Pharma AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2021 was CHF8.11. Hence, Vifor Pharma AG's Price-to-Operating-Cash-Flow Ratio for today is 20.40.

The historical rank and industry rank for Vifor Pharma AG's Price-to-Operating-Cash-Flow or its related term are showing as below:

LTS:0RPD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 15.18   Med: 20.41   Max: 126.33
Current: 21.67

During the past 13 years, Vifor Pharma AG's highest Price-to-Operating-Cash-Flow Ratio was 126.33. The lowest was 15.18. And the median was 20.41.

LTS:0RPD's Price-to-Operating-Cash-Flow is not ranked
in the Drug Manufacturers industry.
Industry Median: 17.14 vs LTS:0RPD: 21.67

Vifor Pharma AG's Cash Flow from Operations per share for the six months ended in Dec. 2021 was CHF5.20. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2021 was CHF8.11.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Vifor Pharma AG was 20.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 43.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 37.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 1.90% per year.

During the past 13 years, Vifor Pharma AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 98.40% per year. The lowest was -44.90% per year. And the median was 10.75% per year.


Vifor Pharma AG Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Vifor Pharma AG's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vifor Pharma AG Price-to-Operating-Cash-Flow Chart

Vifor Pharma AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 126.33 40.60 19.15 21.70 19.75

Vifor Pharma AG Semi-Annual Data
Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.15 - 21.70 - 19.75

Competitive Comparison of Vifor Pharma AG's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Vifor Pharma AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vifor Pharma AG's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vifor Pharma AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vifor Pharma AG's Price-to-Operating-Cash-Flow falls into.



Vifor Pharma AG Price-to-Operating-Cash-Flow Calculation

Vifor Pharma AG's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=165.55/8.114
=20.40

Vifor Pharma AG's Share Price of today is CHF165.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vifor Pharma AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2021 was CHF8.11.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Vifor Pharma AG Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Vifor Pharma AG's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Vifor Pharma AG (LTS:0RPD) Business Description

Traded in Other Exchanges
N/A
Address
Rechenstrasse 37, Saint Gallen, CHE, 9014
Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Vifor Pharma AG (LTS:0RPD) Headlines

No Headlines